Skandinaviska Enskilda Banken (SEB)
LXRX icon

Skandinaviska Enskilda Banken (SEB)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-179,800
Closed -$1.05M – 1100
2021
Q1 		$1.05M Hold
179,800
– – 0.01% 816
2020
Q4 		$615K Hold
179,800
– – ﹤0.01% 880
2020
Q3 		$259K Buy
+179,800
New +$320K ﹤0.01% 890

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s LXRX Position: Q2 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2021, closing a stake of 179,800 shares — an estimated $1.05M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in LXRX in Q3 2020 and held it in 3 quarters. The position peaked at $1.05M in Q1 2021. 107 funds tracked by Wall St. Rank hold LXRX as of Q2 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Lexicon Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 179,800 Lexicon Pharmaceuticals shares in Q2 2021, an estimated $1.05M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Lexicon Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Lexicon Pharmaceuticals position peaked at $1.05M in Q1 2021.
  • 107 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2021, filed 10 Aug 2021.